Advanced NanoTherapies Revenue and Competitors

Location

$5.3M

Total Funding

Estimated Revenue & Valuation

  • Advanced NanoTherapies's estimated annual revenue is currently $2.1M per year.(i)
  • Advanced NanoTherapies's estimated revenue per employee is $133,344
  • Advanced NanoTherapies's total funding is $5.3M.

Employee Data

  • Advanced NanoTherapies has 16 Employees.(i)
  • Advanced NanoTherapies grew their employee count by 0% last year.

Advanced NanoTherapies's People

NameTitleEmail/Phone
1
President, CEO, and co-founderReveal Email/Phone
2
President, CEO and Co-FounderReveal Email/Phone
3
Director - EngineeringReveal Email/Phone
4
Sr. Director R&DReveal Email/Phone
5
Quality ManagerReveal Email/Phone
6
Senior Manager, Product DevelopmentReveal Email/Phone
7
Medical WriterReveal Email/Phone
8
Product Development EngineerReveal Email/Phone
9
Research ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M7920%N/AN/A
#2
$8.5M3111%N/AN/A
#3
$4.5M13-13%N/AN/A
#4
$8M25-4%N/AN/A
#5
$5.3M16-6%N/AN/A
#6
$54.2M163-8%N/AN/A
#7
$12M55-17%N/AN/A
#8
$10M30-9%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M43-7%N/AN/A
Add Company

What Is Advanced NanoTherapies?

AdvNanoT is based on biodegradable nanoparticles (NP) specifically designed to have higher vascular uptake and cellular retention. We are developing novel Sirolimus-based medical devices to treat atherosclerosis and blockage for Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD).

keywords:N/A

$5.3M

Total Funding

16

Number of Employees

$2.1M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.4M16N/AN/A
#2
N/A160%N/A
#3
$1.5M1713%N/A
#4
$28.6M17-79%N/A
#5
$1.6M170%N/A